Study: Under-the-tongue therapy benefits allergy sufferers

12/21/2006 | Reuters

A report says under-the-tongue immunotherapy is cost-effective to treat adults with pollen-induced respiratory allergies. Researchers reviewing the therapy, which is undergoing clinical trails in the U.S., said they found that the treatment can lead to savings by reducing rhinitis and drug consumption.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health